Terms ending in 2032
Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,807,162 | Single Domain VHH Antibodies Against Von Willebrand Factor In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 12,516,105 | Techniques for Predicting, Detecting and Reducing Aspecific Protein Interference in Assays Involving Immunoglobulin Single Variable Domains In force · Medium confidence | Sanofi | In force | Medium confidence | |
| US 12,116,607 | Method for the Production of Domain Antibodies In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 10,118,962 | Methods for Purification of Single Domain Antigen Binding Molecules In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,713,589 | Methods and Compositions for the Preparation of Aerosols In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,007,146 | Methods and Compositions for the Preparation of Aerosols In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,505,840 | Inhibition of Bone Resorption with Rankl Binding Peptides In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,149,089 | A Method for Treating Rheumatoid Arthritis by Administering IL-6 Receptor Antibodies In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,468,679 | Method for Producing Solid Formulations Comprising Immunoglobulin Single Variable Domains In force · High confidence | Ablynx N.V. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Ablynx N.V..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.